Product category:
Microbiology
News Release from: Oxoid
Edited by the Laboratorytalk Editorial
Team on 10 November 2005
Current methods of microbial
identification
Colin Booth of Oxoid will give a presentation at the PharMIG annual conference in November 2005 at Oxford, on 'Current Methods of Microbial Identification
Colin Booth, vice president science and technology at pharmaceutical microbiology specialist Oxoid will be giving a presentation at the PharMIG annual conference (22-23 November 2005, Oxford Belfry Hotel, UK) on 'Current Methods of Microbial Identification' The agenda for this presentation, which will take place during the afternoon of 22 November, includes: Taxonomic changes - an update; Your identification methods give answers, but are they the correct ones?; Your customer is not a microbiologist - try reporting identification results in a language they understand; Viable non-culturable micro-organisms - who cares?; A review and comparison of the best methods of identification
This article was originally published on Laboratorytalk on 18 Jan 2002 at 8.00am (UK)
Related stories
Test to detect C difficile toxin A
Clostridium difficile is thought to be present in up to a fifth of hospital patients, and can cause the life-threatening condition PMC. Oxoid reports continuing sales growth for its diagnostic test
Culture medium for water quality monitoring
Oxoid has launched its water plate count agar, a medium to permit the enumeration of culturable micro-organisms from water using a colony count technique
Oxoid representatives will also be available to provide information on Oxoid's many products for the pharmaceutical industry including the RiboPrinter microbial characterisation system, which is available from Oxoid in Europe and Australia.
The RiboPrinter microbial characterisation system is useful in many applications, including strain-level identification, pinpointing sources of contamination, clinical trial support, research and development, and ensuring culture integrity.
It also allows compliance with the US Food and Drug Administration (FDA) Code of Federal Regulations for electronic record security (21 CFR Part 11).
For pharmaceutical, biotechnical and other FDA-regulated industries, 21 CFR Part 11 compliance is essential for any system that stores data.
The RiboPrinter system stores all information about an analysed isolate, including the ribotype fingerprint, links to any information associated with that pattern, an accurate history of data changes, the source of the isolate, and any additional presumptive identification information obtained. Request free introductory details about products from Oxoid ...
• Oxoid: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
